Literature DB >> 15713381

The discovery and synthesis of novel adenosine receptor (A(2A)) antagonists.

Julius J Matasi1, John P Caldwell, Jinsong Hao, Bernard Neustadt, Leyla Arik, Carolyn J Foster, Jean Lachowicz, Deen B Tulshian.   

Abstract

In high throughput screening of our file compounds, a novel structure 1 was identified as a potent A(2A) receptor antagonist with no selectivity over the A1 adenosine receptor. The structure-activity relationship investigation using 1 as a template lead to identification of a novel class of compounds as potent and selective antagonists of A(2A) adenosine receptor. Compound 26 was identified to be the most potent A(2A) receptor antagonist (Ki = 0.8 nM) with 100-fold selectivity over the A1 adenosine receptor.

Mesh:

Substances:

Year:  2005        PMID: 15713381     DOI: 10.1016/j.bmcl.2005.01.019

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  A simple and facile synthesis of tricyclic-fused pyrimido[4,5-b]indol-2-amines.

Authors:  Wentao Gao; Dongfang Wang; Yang Li
Journal:  Mol Divers       Date:  2017-06-19       Impact factor: 2.943

Review 2.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

3.  Adenosine and its receptors as therapeutic targets: An overview.

Authors:  Sakshi Sachdeva; Monika Gupta
Journal:  Saudi Pharm J       Date:  2012-06-23       Impact factor: 4.330

Review 4.  Progress in the pursuit of therapeutic adenosine receptor antagonists.

Authors:  Stefano Moro; Zhan-Guo Gao; Kenneth A Jacobson; Giampiero Spalluto
Journal:  Med Res Rev       Date:  2006-03       Impact factor: 12.388

5.  Computational studies of the binding modes of A 2A adenosine receptor antagonists.

Authors:  Y Ye; J Wei; X Dai; Q Gao
Journal:  Amino Acids       Date:  2007-11-05       Impact factor: 3.520

6.  Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1 Antagonists.

Authors:  Cristina Val; Carlos Rodríguez-García; Rubén Prieto-Díaz; Abel Crespo; Jhonny Azuaje; Carlos Carbajales; Maria Majellaro; Alejandro Díaz-Holguín; José M Brea; Maria Isabel Loza; Claudia Gioé-Gallo; Marialessandra Contino; Angela Stefanachi; Xerardo García-Mera; Juan C Estévez; Hugo Gutiérrez-de-Terán; Eddy Sotelo
Journal:  J Med Chem       Date:  2022-01-22       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.